Bruker Corporation to Participate in the 2021 Jefferies London Healthcare Conference

Rhea-AI Summary

Bruker Corporation (Nasdaq: BRKR) will take part in the 2021 Jefferies London Healthcare Conference on November 16, 2021, at 12:20 PM GMT. Gerald Herman, Executive Vice President & Chief Financial Officer, will lead an analyst-moderated Q&A session. A live audio webcast can be accessed via the company's Investor Relations website at https://ir.bruker.com. A replay will be available for 30 days post-event in the 'Events & Presentations' section.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will participate in an analyst-moderated question and answer session on behalf of the Company on Tuesday, November 16, 2021 at 12:20 PM GMT.

A live audio webcast of the question and answer session will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005441/en/

Investor Relations

Bruker Corporation

T: +1 (978) 663–3660, ext. 1479

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

When is Bruker Corporation participating in the Jefferies London Healthcare Conference?

Bruker Corporation will participate in the Jefferies London Healthcare Conference on November 16, 2021, at 12:20 PM GMT.

Who will represent Bruker Corporation at the Jefferies London Healthcare Conference?

Gerald Herman, Executive Vice President & Chief Financial Officer, will represent Bruker Corporation at the conference.

How can I listen to the Bruker Corporation's conference session?

You can listen to Bruker Corporation's conference session live via the Investor Relations section of their website at https://ir.bruker.com.

Is a replay available for the Bruker Corporation's conference session?

Yes, a replay of the session will be available for 30 days in the 'Events & Presentations' section of the Bruker Corporation website.